Ribavirin enhances IFN-α signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV.
The nucleoside analogue Ribavirin significantly increases patient response to IFN-α treatment of HCV, by directly inhibiting viral replication. Recent studies indicate that Ribavirin also regulates immunity and we propose that Ribavirin enhances specific interferon sensitive gene (ISG) expression by...
Main Authors: | Nigel J Stevenson, Alison G Murphy, Nollaig M Bourke, Catherine A Keogh, John E Hegarty, Cliona O'Farrelly |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3218071?pdf=render |
Similar Items
-
Polymorphisms of the MxA and MxB genes are associated with biochemical indices and viral subtypes in Yunnan HCV patients
by: Mengzhu He, et al.
Published: (2023-01-01) -
Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature
by: Jamie A. Sugrue, et al.
Published: (2021-11-01) -
The curious case of type I IFN and MxA: Tipping the immune balance in AIDS
by: Andrea Kinga Marias Furuya, et al.
Published: (2014-09-01) -
Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin
by: Sadeq, Refat, et al.
Published: (2013) -
MxA Mediates SUMO-Induced Resistance to Vesicular Stomatitis Virus.
by: Maarifi, G, et al.
Published: (2016)